Loscocco, Giuseppe G.
Vannucchi, Alessandro M. http://orcid.org/0000-0001-5755-0730
Funding for this research was provided by:
Università degli Studi di Firenze
Article History
Received: 20 April 2023
Accepted: 19 May 2023
First Online: 7 June 2023
Declarations
:
: The funders had no role in the design of the study; in the collection, analyses, and interpretation of data; and in the writing of the present manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: G. G. L. has received fees from Novartis; A. M. V. has received speaker fees from Novartis, AOP Health, Incyte, AbbVie, GlaxoSmithKline (GSK), and Bristol Myers Squibb (BMS); and has participated to the advisory boards of Novartis, Incyte, AOP Orphan Pharmaceuticals, AbbVie, GSK, BMS, and Roche.